• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Keratin-associated protein 4-8 (KRTAP4-8)

ACP11591

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP11591 Target NameKRTAP4-8
Target SynonymsKRTAP4-8; KAP4.8; KRTAP4.8; Keratin-associated protein 4-8; Keratin-associated protein 4.8; Ultrahigh sulfur keratin-associated protein 4.8FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-185
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9BYQ9
Background Information
  • Uniprot Id

    Q9BYQ9

  • Target Species

    Human

  • Target Name

    KRTAP4-8

  • Target Full Name

    Keratin-associated protein 4-8

  • Target Function

    In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.

  • Target Protein Families

    KRTAP type 4 family

  • Target Tissue Specificity

    Expressed in the hair follicles.

  • Target Synonyms

    KRTAP4-8; KAP4.8; KRTAP4.8; Keratin-associated protein 4-8; Keratin-associated protein 4.8; Ultrahigh sulfur keratin-associated protein 4.8

Inquire Recombinant Human Keratin-associated protein 4-8 (KRTAP4-8) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification